// News

November 30, 2017: In the Know

Tags: , , , , ,

  1. Genetic Markers in Advanced Prostate Cancer Could Explain Treatment Resistance
  2. This Cancer Survivor’s Startup Wants to Take the Danger out of Drug Testing
  3. Skyview Ventures Makes Significant Investment in Silk Technologies, Ltd.
  4. Takeda moves ahead in Zika race with launch of vaccine trial
  5. MGC Diagnostics Corporation Agrees To Be Acquired By Altus Capital Partners
  6. Medtronic wins FDA nod for Azure remote monitoring equipped pacers
  7. ‘Sleeping Beauty’ puts U of M’s licensing revenue at No. 2 among Big Ten
  8. Magenta Therapeutics Finds A “Support Chain” Beyond CDMOs
  9. Rebiotix Announces Expansion of Phase 1 Trial of the Company’s Oral Capsule Microbiota Product, RBX7455, Following Successful Completion of Initial Study Arms
  10. One in a Million: The journey to a new life after bone marrow transplant
  11. Mayo Clinic develops neuro test that distinguishes demyelinating diseases from MS
  12. Medtronic Launches New Telehealth Solutions in Support of U.S. Department of Veterans Affairs

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER